Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents of Black Bird Biotech, Inc. from 31 Dec 2020 to 30 Sep 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Summary
Black Bird Biotech, Inc. quarterly Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents in USD history and change rate from 31 Dec 2020 to 30 Sep 2023.
  • Black Bird Biotech, Inc. Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents for the quarter ending 30 Sep 2023 was $5,729, a 91% decline year-over-year.
Source SEC data
View on sec.gov
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Quarterly (USD)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, YoY Quarterly Change (%)

Black Bird Biotech, Inc. Quarterly Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2023 $5,729 -$60,447 -91% 30 Sep 2023 10-Q 20 Nov 2023 2023 Q3
Q2 2023 $6,720 -$45,802 -87% 30 Jun 2023 10-Q 21 Aug 2023 2023 Q2
Q1 2023 $7,234 -$98,326 -93% 31 Mar 2023 10-Q 22 May 2023 2023 Q1
Q4 2022 $44,448 -$455,318 -91% 31 Dec 2022 10-Q 20 Nov 2023 2023 Q3
Q3 2022 $66,176 -$753,938 -92% 30 Sep 2022 10-Q 20 Nov 2023 2023 Q3
Q2 2022 $52,522 -$14,224 -21% 30 Jun 2022 10-Q 21 Aug 2023 2023 Q2
Q1 2022 $105,560 +$29,772 +39% 31 Mar 2022 10-Q 22 May 2023 2023 Q1
Q4 2021 $499,766 +$446,792 +843% 31 Dec 2021 10-Q 20 Nov 2023 2023 Q3
Q3 2021 $820,114 30 Sep 2021 10-Q 14 Nov 2022 2022 Q3
Q2 2021 $66,746 30 Jun 2021 10-Q 23 Aug 2022 2022 Q2
Q1 2021 $75,788 31 Mar 2021 10-Q 23 May 2022 2022 Q1
Q4 2020 $52,974 31 Dec 2020 10-K 21 Mar 2023 2022 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.